Allergy Research Has IQ03 Sales Increase
July 21, 2003
1 Min Read
Allergy Research Has IQ03 Sales Increase
HAYWARD, Calif.--Allergy Research Group Inc. (OTCBB:ALRG),makers of hypoallergenic nutritional supplements, reported May 15 that for itsfirst quarter (1Q03), ended March 31, it had a 15-percent increase in sales to$3.4 million. Net income also rose, to $500,000 from $300,000 logged the sameperiod prior. "We are very pleased by the increase in sales but remaincautious as to our ability to sustain this momentum throughout 2003," saidStephen Levine, Ph.D., chief executive officer and chairman.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like